PI Settlement Timeline and Medication Access: What Attorneys Need to Know

James Wong — Founder & Pharmacist, LienScripts | February 11, 2026 | 8 min read

Personal injury cases take 12 to 24 months to settle. Here is how pharmacy liens bridge every medication access gap across the full arc of a PI case — from ER discharge through final settlement.

The Medication Access Problem Nobody Talks About

When a client walks into your office two weeks after an auto accident, they are usually still in acute pain. They have seen an ER physician, possibly an urgent care provider, and maybe a chiropractor. They have a handful of prescriptions — a muscle relaxant, an NSAID, perhaps a short course of something for sleep disruption. And they have a problem: they have no idea how they are going to keep paying for those prescriptions for the next 12 to 24 months while the case resolves.

This is the medication access gap. It is one of the most underappreciated logistical challenges in personal injury practice, and it directly affects case outcomes. Clients who cannot access medication stop treating. Clients who stop treating produce medical records that look like their injuries resolved when they did not. Adjusters use treatment gaps to argue that the client has reached maximum medical improvement prematurely, or worse, that the injuries were not as severe as claimed.

Pharmacy liens exist to close this gap. But understanding when and why medication access breaks down requires understanding the full PI settlement timeline.

The Full PI Case Timeline: Where Medication Access Fails

Most personal injury cases follow a recognizable arc. The specific durations vary, but the structure is consistent:

Phase 1: Acute Care (Weeks 1-4)

The client receives emergency or urgent care immediately after the accident. Prescriptions are typically written by the ER physician, hospitalist, or urgent care provider. Insurance coverage — whether auto MedPay, employer health insurance, or a combination — usually covers this phase without immediate friction.

The medication access problem is not visible yet. But several clocks have quietly started.

Phase 2: Initial Treatment and Prescription Ramp-Up (Months 1-3)

The client is referred to specialists: an orthopedic surgeon, a neurologist, a pain management physician. Diagnoses are formalized — herniated discs, nerve impingement, traumatic brain injury. Medication regimens become more complex and longer in duration.

This is where the first access failures begin to appear. Health insurance plan year deductibles reset. MedPay limits ($5,000-$10,000 on most policies) are approaching exhaustion. If the client has employer health insurance through an employer who requires reporting injuries, the insurer may begin asking questions about whether the treatment is injury-related — and some plans begin asserting subrogation rights that create administrative friction at the pharmacy.

[!KEY] MedPay exhaustion is the most common trigger for pharmacy lien enrollment. Most MedPay policies cap out between $5,000 and $25,000. Once exhausted, clients with no secondary coverage face immediate out-of-pocket pharmacy costs that many cannot sustain. Enrolling the client with a pharmacy lien provider at intake — before MedPay runs out — avoids a treatment gap entirely.

Phase 3: Ongoing Treatment (Months 3-9)

By this point, many clients are managing a chronic pain regimen. The medication list may include a muscle relaxant, a nerve pain agent like gabapentin or pregabalin, a topical anti-inflammatory, and possibly a proton pump inhibitor to protect the stomach from long-term NSAID use.

Health insurance subrogation notices arrive. COBRA election windows open for clients who have lost employment. Workers' compensation cases that overlap with the personal injury case create an adjudication tangle that freezes medication access while the two carriers dispute primary liability.

Without a pharmacy lien, clients in this phase routinely discontinue one or more medications because they cannot afford the out-of-pocket cost. Each discontinuation is a gap in the treatment record.

Phase 4: MMI and Pre-Demand (Months 9-18)

The treating physician declares maximum medical improvement (MMI). This triggers a cascade of events: the workers' comp carrier (if applicable) may terminate benefits, the health insurance subrogation claim crystallizes, and the pain management provider may begin reducing or stopping prescriptions.

MMI does not mean the client is pain-free. It means their condition has stabilized. Many clients continue medications post-MMI for ongoing symptom management. The pharmacy lien continues to cover those medications until settlement.

Phase 5: Demand, Negotiation, and Settlement (Months 12-24)

The demand letter goes out. Negotiations begin. In complex cases — disputed liability, high-value injuries, policy limit negotiations — this phase can extend a year or more beyond MMI.

[!KEY] The settlement does not close the day the demand letter is sent. Pharmacy lien coverage must extend through the entire negotiation phase, not just through MMI. Attorneys should confirm with their pharmacy lien provider that coverage remains active until a settlement check is issued and the lien is paid.

Phase 6: Settlement Disbursement and Lien Payoff

The settlement funds arrive. The attorney handles the lien payoff to the pharmacy, along with any other lien obligations, and disburses the net recovery to the client. The pharmacy lien lifecycle is complete.

Specific Coverage Gaps and How Pharmacy Liens Address Each One

Practical Advice for Intake and Enrollment Timing

The single most impactful decision an attorney can make regarding pharmacy liens is when to enroll the client. The answer is: at intake, before any access gap occurs.

Waiting until MedPay runs out means the client has already had a gap. Waiting until the client calls you asking how to pay for their prescriptions means the damage is already partially done. Proactive enrollment at intake eliminates the problem entirely.

[!SOURCE] California courts have consistently held that the reasonable value of medical services — including prescription medications — is recoverable as special damages in personal injury actions. See Hanif v. Housing Authority, 200 Cal.App.3d 635 (1988) (reasonable value standard) and Howell v. Hamilton Meats & Provisions, Inc., 52 Cal.4th 541 (2011) (discussing admissible evidence of past medical expense value in California). Pharmacy lien charges represent the billed rate for deferred-payment pharmaceutical services and are properly included in past medical expense calculations.

What to Tell Clients at Intake

A straightforward explanation at the initial consultation removes confusion and builds trust: "Because it can take a year or more to resolve your case, you need a way to get your prescriptions filled without paying out of pocket. We work with a pharmacy lien program that covers your medications. The pharmacy is paid from your settlement, just like your doctors and other providers. You will not owe anything upfront."

This framing is accurate, compliant, and easy for clients to understand. It also heads off the single most common reason clients stop filling prescriptions: they assume they have to pay now.

The Downstream Case Value Impact

Continuous, documented medication adherence does more than keep your client comfortable. It produces a medication history that corroborates the severity and duration of the injury. A complete pharmacy dispensing record — showing 14 months of consistent fills for a nerve pain agent and muscle relaxant — tells a story about an injury that did not resolve quickly and required ongoing management.

That story has value at the negotiating table. Gaps in the medication record tell the opposite story, and adjusters know how to read them.

Related Resources

• What Is a Pharmacy Lien?
• Pharmacy Lien: No Out-of-Pocket Cost for Patients
• Health Insurance Subrogation vs. Pharmacy Lien
• MedPay and Pharmacy Liens in California (GEICO)
• State Farm MedPay Subrogation and Pharmacy Liens